Using ELISpot technology to improve the diagnosis of tuberculosis infection: From the bench to the T-SPOT.TB assay

Expert Review of Respiratory Medicine

Volumn 2, Issue 2, 2008, Pages 253-260

  Richeldi, Luca ^a   Losi, Monica ^a   Cerri, Stefania ^a   Casali, Lucio ^b   Fabbri, Leonardo M ^a   Ferrara, Giovanni ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Diagnosis; ELISpot; IFN ; Immunosuppression; Tubercolosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ANTIGEN DETECTION; BCG VACCINATION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; IMMUNE DEFICIENCY; INTERMETHOD COMPARISON; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 47249117090     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.2.2.253     Document Type: Review

References (51)

1. Kaufmann SH. A short history of Robert Koch's fight against tuberculosis: those who do not remember the past are condemned to repeat it. Tuberculosis (Edinb.) 83(1-3), 86-90 (2003).
2. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin. Infect. Dis. 17(6), 968-975 (1993).
3. Flynn JL, Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93-129 (2001).
4. Pai M, Riley LW, Colford JM Jr. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis. 4(12), 761-776 (2004).
5. Richeldi L. An update on the diagnosis of tuberculosis infection. Am. J. Respir. Crit. Care Med. 174(7), 736-742 (2006).
6. Mazurek GH, LoBue PA, Daley CL et al. Comparison of a whole-blood interferon γ assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 286(14), 1740-1747 (2001).
7. Cole ST, Brosch R, Parkhill J et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393(6685), 537-544 (1998).
8. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect. Immun. 64(1), 16-22 (1996).
9. Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect. Immun. 63(5), 1710-1717 (1995).
10. Lalvani A, Hurt N, Aidoo M, Kibatala P. Tanner M, Hill AV. Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania. Eur. J. Immunol. 26(4), 773-779 (1996).
11. + T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 95(1), 270-275 (1998).
12. Chapman AL, Munkanta M, Wilkinson KA et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16(17), 2285-2293 (2002).
13. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 364(9452), 2196-2203 (2004).
14. Lalvani A, Pathan AA, Durkan H et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357(9273), 2017-2221 (2001).
15. Richeldi L, Ewer K, Losi M et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am. J. Respir. Crit. Care Med. 170(3), 288-295 (2004).
16. Zellweger JP, Zellweger A, Ansermet S, de Senarclens B, Wrighton-Smith P. Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int. J. Tuberc. Lung Dis. 9(11), 1242-1247 (2005).
17. Shams H, Weis SE, Klucar P et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 172(9), 1161-1168 (2005).
18. Lee JY, Choi HJ, Park IN et al. Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection. Eur. Respir. J. 28(1), 24-30 (2006).
19. Adetifa IM, Lugos MD, Hammond A et al. Comparison of two interferon γ release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect. Dis. 7(1), 122 (2007).
20. Detjen AK, Keil T, Roll S et al. Interferon-γ release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin. Infect. Dis. 45(3), 322-328 (2007).
21. Soysal A, Millington KA, Bakir M et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 366(9495), 1443-1451 (2005).
22. Naseer A, Naqvi S, Kampmann B. Evidence for boosting Mycobacterium tuberculosis-specific IFN-γ responses at 6 weeks following tuberculin skin testing. Eur. Respir. J. 29(6), 1282-1283 (2007).
23. Richeldi L, Ewer K, Losi M, Roversi P, Fabbri LM, Lalvani A. Repeated tuberculin testing does not induce false positive ELISPOT results. Thorax 61(2), 180 (2006).
24. Hill PC, Brookes RH, Fox A et al. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med 4(6), e192 (2007).
25. Richeldi L, Ewer K, Losi M et al. Early diagnosis of subclinical multidrug-resistant tuberculosis. Ann. Intern. Med. 140(9), 709-713 (2004).
26. Richeldi L, Ewer K, Losi M et al. T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. Pediatrics 119(1), e1-e5 (2007).
27. Richeldi L, Luppi M, Losi M et al. Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. Leukemia 20(2), 379-381 (2006).
28. Ferrara G, Losi M, D'Amico R et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367(9519), 1328-1334 (2006).
29. Piana F, Ruffo Codecasa L, Baldan R, Miotto P, Ferrarese M, Cirillo DM. Use of T-SPOT. TB in latent tubercolosis infection diagnosis in general and immunosuppressed populations. New Microbiol. 30(3), 286-290 (2007).
30. Arend SM, Thijsen SF, Leyten EM et al. Comparison of two interferon-γ assays and tuberculin skin test for tracing tuberculosis contacts. Am. J. Repir. Crit. Care Med. 175(6), 618-627 (2007).
31. Piana F, Codecasa LR, Cavallerio P et al. Use of a T-cell-based test for detection of tuberculosis infection among immunoocompromised patients. Eur. Respir. J. 28(1), 31-34 (2006).
32. Clark SA, Martin SL, Pozniak A et al. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodefeciency virus (HIV)-1 patients with advanced disease. Clin. Exp. Immunol. 150(2), 238-244 (2007).
33. Goletti D, Carrara S, Vincenti D et al. Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. Clin. Microbiol. Infect. 12(6), 544-550 (2006).
34. Kang YA, Lee HW, Hwang SS et al. Usefulness of whole-blood interferon-γ assay and interferon-γ enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 132(3), 959-965 (2007).
35. van Leeuwen RM, Bossink AW, Thijsen SF. Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOT. TB assay. Eur. Respir. J. 29(3), 605-607 (2007).
36. Gooding S, Chowdhury O, Hinks T et al. Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practice. J. Infect. 54(3), e169-e174 (2007).
37. Kim SH, Choi SJ, Kim HB, Kim NJ, Oh MD, Choe KW. Diagnostic usefulness of a T-cell based assay for extrapulmonary tuberculosis. Arch. Intern. Med. 167(20), 2255-2259 (2007).
38. Mazurek GH, Weis SE, Moonan PK et al. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-γ release assays in persons with suspected tuberculosis. Clin. Infect. Dis. 45(7), 837-845 (2007).
39. Wilkinson KA, Wilkinson RJ, Pathan A et al. Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin. Infect. Dis. 40(1), 184-187 (2005).
40. Losi M, Bossink A, Codecasa L et al. Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy. Eur. Respir. J. 30(6), 1173-1179 (2007).
41. Jafari C, Ernst M, Kalsdorf B et al. Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am. J. Rrspir. Crit. Care Med. 174(9), 1048-1054 (2006).
42. Adetifa IM, Brookes R, Lugos MD et al. Rising ELISPOT count prior to the onset of symptoms of full-blown tuberculosis disease. Int. J. Tuberc. Lung Dis. 11(3), 350-352 (2007).
43. Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin. Infect. Dis. 38(5), 754-756 (2004).
44. Chee CB, KhinMar KW, Gan SH, Barkham TM, Pushparani M, Wang YT. latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigengs. Am. J. Respir. Crit. Care Med. 175(3), 282-287 (2007).
45. Aiken AM, Hill PC, Fox A et al. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Inject. Dis. 6, 66 (2006).
46. Janssens JP, Roux-Lombard P, Perneger T, Metzger M, Vivien R, Rochat T. Quantitative scoring of a γ-interferon assay for differentiating active from latent tuberculosis. Eur. Respir. J. 30(4), 722-728 (2007).
47. National Institute for Health and Clinical Excellence. Tuberculosis. Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control. London, UK (2006).
48. Wrighton-Smith P, Zellweger JP. Direct costs of three models for the screening of latent tuberculosis infection. Eur. Respir. J. 28(1), 45-50 (2006).
49. Millington KA, Innes JA, Hackforth S et al. Dynamic relationship between IFN-γ and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J. Immunol. 178(8), 5217-5226 (2007).
50. Lawn SD, Bangani N, Vogt M et al. Utility of interferon-γ ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Inject. Dis. 7, 99 (2007).
51. Perkins MD, Cunningham J. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J. Infect. Dis. 196(Suppl. 1), S15-S27 (2007).